WHO May Reject Canadian-Made Medicago COVID-19 Vaccine Because of Ties to Big Tobacco

A vial of a plant-derived COVID-19 vaccine candidate, developed by Medicago, is shown in Quebec City on July 13, 2020. The Canadian Press/HO, Medicago

The World Health Organization says it is expecting to reject the COVID-19 vaccine candidate from Canada’s Medicago because of the company’s ties to big tobacco.

The Medicago Covifenz vaccine was authorized in Canada last month.